Literature DB >> 23043135

Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature.

Richard H Schwartz1, Otilia Neacsu, David P Ascher, Oral Alpan.   

Abstract

Inhaled corticosteroids (ICS) are drugs of choice for persistent asthma. Less than 500 µg/d of fluticasone are believed to be safe. We found 92 cases of adrenal suppression in PubMed; among these cases there were 13 children who took 500 µg/d or less of fluticasone. Adrenal insufficiency was diagnosed in a 7-year-old boy on 460 µg ICS for 16 months, with a diagnosis of chronic persistent asthma. A random cortisol was nondetectable as was an early morning cortisol. ICS have greatly improved the day-to-day lives of children with chronic persistent asthma. Parents of children younger than 12 years, who use at least 400 µg of inhaled fluticasone (or bioequivalent), must be given oral and written instructions about warning symptoms of hypocortisolism. Major stress such as surgery, gastrointestinal, bronchopulmonary, or other systemic infections, and heat stress may mandate a written plan of action for use by hospital physicians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043135     DOI: 10.1177/0009922812462235

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  12 in total

Review 1.  Asthma and Medicines - Long-Term Side-Effects, Monitoring and Dose Titration.

Authors:  Satnam Kaur; Varinder Singh
Journal:  Indian J Pediatr       Date:  2018-01-06       Impact factor: 1.967

Review 2.  Recovery of steroid induced adrenal insufficiency.

Authors:  Areej K Younes; Noor K Younes
Journal:  Transl Pediatr       Date:  2017-10

Review 3.  Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity.

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

4.  Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.

Authors:  Ozlem Cavkaytar; Dogus Vuralli; Ebru Arik Yilmaz; Betul Buyuktiryaki; Ozge Soyer; Umit M Sahiner; Nurgun Kandemir; Bulent E Sekerel
Journal:  Eur J Pediatr       Date:  2015-08-09       Impact factor: 3.183

Review 5. 

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

Review 6.  Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.

Authors:  John Blakey; Li Ping Chung; Vanessa M McDonald; Laurence Ruane; John Gornall; Chris Barton; Sinthia Bosnic-Anticevich; John Harrington; Mark Hew; Anne E Holland; Trudy Hopkins; Lata Jayaram; Helen Reddel; John W Upham; Peter G Gibson; Philip Bardin
Journal:  Respirology       Date:  2021-09-29       Impact factor: 6.175

7.  Adrenal insufficiency in a woman secondary to standard-dose inhaled fluticasone propionate therapy.

Authors:  Casey M Hay; Daniel I Spratt
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-02-01

8.  Inhaled corticosteroids and secondary adrenal insufficiency.

Authors:  Vishnu Sannarangappa; Ryan Jalleh
Journal:  Open Respir Med J       Date:  2014-01-31

Review 9.  The use of inhaled corticosteroids in pediatric asthma: update.

Authors:  Elham Hossny; Nelson Rosario; Bee Wah Lee; Meenu Singh; Dalia El-Ghoneimy; Jian Yi Soh; Peter Le Souef
Journal:  World Allergy Organ J       Date:  2016-08-12       Impact factor: 4.084

10.  Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis.

Authors:  Gregory Constantine; Neha Seth; Niti Chokshi; Charles G Minard; Danielle Guffey; Anthony P Olive; Carla M Davis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-06       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.